McCulloch Kevin 内部人交易：近期 SEC Form 4 交易
过去 18 个月，McCulloch Kevin（CIK 2031695）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 15,000 | $141,120 |
| 2026-09-29 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 25,000 | $250,000 |
| 2026-09-01 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 15,000 | $127,308 |
| 2026-08-21 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 21,918 | $177,097 |
| 2026-08-04 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 15,000 | $120,240 |
| 2026-07-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | 卖出 | 90,000 | $722,511 |
| 2026-03-16 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 买入 | 48,894 | $199,976 |
| 2026-03-16 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 买入 | 4 | $16 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 买入 | 168,463 | $0 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 68,454 | $503,821 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 30,289 | $222,927 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 27,319 | $201,068 |
| 2026-01-09 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 15,000 | $120,000 |
| 2025-10-03 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 733 | $6,091 |
| 2025-09-15 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 2,000 | $0 |
| 2025-08-04 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 卖出 | 14,651 | $78,822 |
| 2025-06-16 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | 买入 | 25,000 | $109,500 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02